Cargando…
Achieving consensus over the assessment of clinical signs in eczema trials
Autores principales: | Thomas, Kim S, Schmitt, Jochen, Spuls, Phyllis I, Simpson, Eric, Furue, Masutaka, Deckert, Stefanie, Apfelbacher, Christian, Chalmers, Joanne, Williams, Hywel C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4460656/ http://dx.doi.org/10.1186/1745-6215-16-S1-P19 |
Ejemplares similares
-
Measurement properties of adult quality-of-life measurement instruments for eczema: protocol for a systematic review
por: Apfelbacher, Christian J, et al.
Publicado: (2015) -
TREatment of ATopic eczema (TREAT) Registry Taskforce: consensus on how and when to measure the core dataset for atopic eczema treatment research registries
por: Vermeulen, F.M., et al.
Publicado: (2019) -
Recommended core outcome instruments for health‐related quality of life, long‐term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting
por: Thomas, K.S., et al.
Publicado: (2021) -
Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME)
por: Chalmers, JR, et al.
Publicado: (2014) -
Development and initial testing of a new instrument to measure the experience of eczema control in adults and children: Recap of atopic eczema (RECAP)
por: Howells, L.M., et al.
Publicado: (2020)